Restenosis risk factors after coronary stenting in metabolic syndrome patients
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus. Recently, MS has also been regarded as a pathology enhancing coronary restenosis risk. Certain...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
| Rangatū: | Кардиоваскулярная терапия и профилактика |
| Ngā marau: | |
| Urunga tuihono: | https://cardiovascular.elpub.ru/jour/article/view/1207 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|